# LEIDOS FUNDING TO25, OPTION 1 MEASLES

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2024 · $2,140,115

## Abstract

Infectious diseases remain one of the leading causes of death worldwide despite innovations in medical research and the availability of new treatments. Emerging diseases include outbreaks of previously unknown diseases or known diseases where the incidence in humans has significantly increased in the past two decades. Detailed studies on emerging and re-emerging infectious agents to better understand pathogens’ biology and host pathogenesis are mostly lacking. The initial study protocol under this Task Order is to prepare for a rapid coordinated clinical investigation of acute infections of emerging and re-emerging infectious agents.

## Key facts

- **NIH application ID:** 11197833
- **Project number:** 75N91019D00024-P00010-759102000025-4
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** ETHAN DMITROVSKY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,140,115
- **Award type:** —
- **Project period:** 2020-09-28 → 2028-09-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11197833

## Citation

> US National Institutes of Health, RePORTER application 11197833, LEIDOS FUNDING TO25, OPTION 1 MEASLES (75N91019D00024-P00010-759102000025-4). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11197833. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*